
Multiple Myeloma Patient Safety and the Coronavirus
Double-click on the image above to view a replay of the teleconference.
As the COVID-19 respiratory virus spreads across the country and around the world, myeloma patient safety is a paramount concern of patients, families and caregivers.
Please JOIN the International Myeloma Foundation for this timely and important live webinar Multiple Myeloma Patient Safety and the Coronavirus, featuring myeloma experts sharing the latest updates, insights and resources to help keep you safe.
There will be an opportunity for questions for our speaker panel during the webinar
with support from:
Bristol Myers Squibb, Janssen Oncology, and Takeda Oncology
Previous Post
COVID-19 FAQ #3: Do myeloma patients need to adjust their treatment?
Next Post
COVID-19 FAQ #4: What are some of the treatment modifications myeloma patients should consider?